← Back to Patent Explorer
US4645829A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for separating polypeptides

Assignee: Monsanto Technology LLC
•
Filing: 1984-10-29
•
Granted: 1987-02-24
•
Expires: 2004-10-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of separating a first polypeptide fraction from a second polypeptide fraction of a mixed solution is disclosed. A predetermined charged polymer is admixed with the mixed solution preferably in the presence of a neutral polymer. The charged polymer interacts with the first fraction to form a precipitate. The neutral polymer enhances the effectiveness of the charged polymer in precipitating the first fraction. By proper selection of the polymer combination the desired polypeptide fraction can be precipitated from solution leaving the other polypeptide fraction in solution or vice versa.

Inventors

  • 👤 Sa Van Ho

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 11:02
CPC Classifications
C; C07; C07K; C07K1/00; C07K1/14; C07K1/30; C07K1/32; Y; Y10; Y10S; Y10S210/00; Y10S210/902; Y10S210/903; Y10S210/905

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 83 words
A method of separating a first polypeptide fraction from a second polypeptide fraction of a mixed solution containing said fractions which comprises admixing at least one neutral polymer and at least one charged polymer with said solution, said charged polymer being soluble in said mixed solution and interacting with said first fraction to form an interaction product which precipitates from solution, said neutral polymer being soluble in said mixed solution and enhancing the effectiveness of said charged polymer in precipitating said first fraction.
Claim 2
Independent Claim 83 words
A method of separating a first polypeptide fraction from a second polypeptide fraction of a mixed solution containing said fractions which comprises admixing at least one neutral polymer and at least one charged polymer with said solution, said charged polymer being soluble in said mixed solution and interacting with said first fraction to form an interaction product which precipitates from solution, said neutral polymer being soluble in said mixed solution and enhancing the effectiveness of said charged polymer in precipitating said first fraction.
Claim 3
Dependent Claim 17 words
A method of claim 1 in which the mixed solution comprising the polypeptides is an aqueous solution.
Claim 4
Dependent Claim 22 words
A method of claim 2 in which the charged polymer is admixed with the solution in the presence of the neutral polymer.
Claim 5
Dependent Claim 27 words
A method of claim 2 in which the effectiveness of the charged polymer is enhanced by lowering the concentration of the charged polymer required to cause precipitation.
Claim 6
Dependent Claim 28 words
A method of claim 2 in which the effectiveness of the charged polymer is enhanced by increasing the selectivity of the charged polymer for precipitating said first fraction.
Claim 7
Dependent Claim 14 words
A method of claim 2 in which the mixed solution comprises a cell extract.
Claim 8
Dependent Claim 14 words
A method of claim 2 in which the mixed solution is a fermentation broth.
Claim 9
Dependent Claim 16 words
A method of claim 2 in which a biologically active polypeptide is separated from contaminating polypeptides.
Claim 10
Dependent Claim 15 words
A method of claim 2 in which a mammalian hormone is separated from contaminating polypeptides.
Claim 11
Dependent Claim 15 words
A method of claim 2 in which an avian hormone is separated from contaminating polypeptides.
Claim 12
Dependent Claim 14 words
A method of claim 2 in which a somatotropin is separated from contaminating polypeptides.
Claim 13
Dependent Claim 46 words
A method of claim 2 in which the charged and neutral polymers are chosen such that the neutral polymer is substantially similar in hydrophobic/hydrophilic character to said second fraction or substantially dissimilar in hydrophobic/hydrophilic character to the interaction product of said charged polymer and first fraction.
Claim 14
Dependent Claim 34 words
A method of claim 2 in which said second fraction is more hydrophobic than said interaction product and the neutral polymer is more like said second fraction than said interaction product in hydrophobic/hydrophilic character.
Claim 15
Dependent Claim 35 words
A method of claim 2 in which said interaction product is more hydrophobic than said second fraction and the neutral polymer is more like said second fraction than said interaction product in hydrophobic hydrophilic character.
Claim 16
Dependent Claim 14 words
A method of claim 2 in which the polypeptide fractions consist essentially of proteins.
Claim 17
Independent Claim 75 words
A method of separating a bovine somatotropin fraction from a contaminating polypeptide fraction of a mixed solution which comprises admixing at least one neutral polymer and at least one charged polymer with said solution, said charged polymer being soluble in said mixed solution and interacting with one of the fractions thereby precipitating said fraction, said neutral polymer being soluble in said mixed solution and enhancing the effectiveness of said charged polymer in precipitating said fraction.
Claim 18
Independent Claim 75 words
A method of separating a bovine somatotropin fraction from a contaminating polypeptide fraction of a mixed solution which comprises admixing at least one neutral polymer and at least one charged polymer with said solution, said charged polymer being soluble in said mixed solution and interacting with one of the fractions thereby precipitating said fraction, said neutral polymer being soluble in said mixed solution and enhancing the effectiveness of said charged polymer in precipitating said fraction.
Claim 19
Dependent Claim 19 words
A method of claim 16 in which the mixed solution comprising the bovine sometotropin fraction is an aqueous solution.
Claim 20
Dependent Claim 31 words
A method of claim 17 in which the contaiminating proteins are precipitated by the addition of diethylaminoethyldextran and the effectiveness of said diethylaminoethyldextran is enhanced by the addition of polyethylene glycol.
Claim 21
Dependent Claim 31 words
A method of claim 17 in which the contaminating proteins are precipitated by the addition of diethylaminoethyldextran and the effectiveness of said diethylaminoethyldextran is enhaneed by the addition of polypropylene glycol.
Claim 22
Dependent Claim 30 words
A method of claim 17 in which the contaminating proteins are precipitated by the addition of diethylaminoethyldextran and the effectiveness of said diethylaminoethyldextran is enhanced by the addition of polyvinylalcohol.
Claim 23
Dependent Claim 31 words
A method of claim 17 in which the contaminating proteins are precipitated by the addition of polyehtyleneimine and the effectiveness of said polyethyleneimine is enhanced by the addition of polyethylene glycol.
Claim 24
Dependent Claim 34 words
A method of claim 17 in which the contaminating proteins are precipitated by the addition of a cationic polyamine and the effectiveness of said cationic polyamine is enhanced by the addition of polyethylene glycol.
Claim 25
Dependent Claim 38 words
A method of claim 17 in which N-methionyl bovine somatotropin is separated by the precipitation of the contaminating proteins by the addition of diethylaminoethyldextran and the effectiveness of said diethylainoethyldextran is enhanced by the addition of polyethylene glycol.
Claim 26
Dependent Claim 36 words
A method of claim 17 in which N-methionyl bovine somatotropin is separated from contaminating E. coli proteins by the addition of diethylaminoethyldextran and the effectiveness of said diethylaminoethyldextran is enhanced by the additional of polyethylene glycol.
Claim 27
Dependent Claim 20 words
A method of claim 24 in which the separation is conducted at a solution pH between about 9 and 12.

References Cited (Backward Citations)

US3655509A Cited
US3994806A Cited
US4357272A Cited
US4518769A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-02-23 1990-08-25 1991-02-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-02-23 1994-08-25 1995-02-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-02-23 1998-08-25 1999-02-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag